Product Information
KETOROLAC 0.5% OPHTH SOLUTION is a generic product labeled by Leading Pharma, LLC, priced at $1.4508 per ML under NDC 69315032205. Its NADAC has been published 110 times since Aug 28, 2024.
FDA first approved this application on Mar 26, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
5 mg/mL
Manufacturer
Leading Pharma, LLCNDC
69315032205
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA218204FDA Approved
3/26/2024
TE Code
AT
On Market Since
6/1/2024
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 0.5% OPHTH SOLUTION has been published 110 times since Aug 28, 2024, and over the history we have for it it has risen 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4508 per ML |
|---|---|
| All-time high | $1.5406 (Jan 14, 2026) |
| All-time low | $1.2064 (Nov 20, 2024) |
| 52-week high | $1.5406 |
| 52-week low | $1.3991 |
| Median price | $1.4431 |
| Average price | $1.4364 |
| Largest weekly change | -18.5% (Nov 20, 2024) |
| Weeks tracked | 110 |
| Tracking since | Aug 28, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ketorolac Tromethamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cyclooxygenase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOROLAC 0.5% OPHTH SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 0.5% OPHTH SOLUTION, manufactured by Leading Pharma, LLC, is $1.4508 per ML (NDC 69315032205), effective Sep 30, 2026.
How has the price of KETOROLAC 0.5% OPHTH SOLUTION changed over time?
Over the history we have for it, the NADAC for KETOROLAC 0.5% OPHTH SOLUTION has risen 6.2%. It has been tracked across 110 weekly CMS publications since Aug 28, 2024.
What are the highest and lowest recorded NADAC prices for KETOROLAC 0.5% OPHTH SOLUTION?
Since Aug 28, 2024, the NADAC for KETOROLAC 0.5% OPHTH SOLUTION has ranged from a low of $1.2064 (Nov 20, 2024) to a high of $1.5406 (Jan 14, 2026), with a median of $1.4431 per ML.
Are there cheaper alternatives to KETOROLAC 0.5% OPHTH SOLUTION?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOROLAC 0.5% OPHTH SOLUTION, is $1.3384 per ML — about 8% below KETOROLAC 0.5% OPHTH SOLUTION.
Who manufactures KETOROLAC 0.5% OPHTH SOLUTION?
KETOROLAC 0.5% OPHTH SOLUTION (NDC 69315032205) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.